Sarepta TherapeuticsSRPT
那斯達克 · USD
16.42
-0.33
(-1.97%)
收盤 08/01 03:59 (UTC+8)
盤後
16.40
16.40
(-0.12%)
08/01 03:59 (UTC+8)
Sarepta TherapeuticsSRPT
16.42
-0.33
(-1.97%)
財務數據
損益表
- 2.58
- 2.54
- 2.61
- 3.32
- 3.97
- 4.13
- 3.63
- 4.67
- 6.58
- 7.45
- 12.23
- -1.91
- 3.05
- 27.02
- 19.58
- 4.20
- -12.22
- 28.72
- 40.94
- 13.13
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 744,856 | 658,412 | 467,172 | 362,931 | 413,464 | 396,781 | 331,817 | 261,238 | 253,500 | 258,427 |
營業成本 | 137,564 | 132,304 | 91,691 | 44,545 | 50,559 | 44,176 | 37,026 | 34,124 | 35,017 | 30,799 |
營業毛利 | 607,292 | 526,108 | 375,481 | 318,386 | 362,905 | 352,605 | 294,791 | 227,114 | 218,483 | 227,628 |
營業費用 | 907,678 | 364,427 | 353,285 | 319,087 | - | 327,980 | 315,633 | 360,633 | 356,571 | 334,461 |
研發費用 | 773,448 | 199,953 | 224,483 | 179,690 | 200,396 | 195,517 | 194,301 | 241,890 | 245,679 | 213,804 |
推銷及管理費用 | 133,629 | 163,873 | 128,200 | 138,796 | 127,003 | 131,700 | 120,893 | 118,564 | 110,714 | 120,478 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 601 | 601 | 602 | 601 | 601 | 763 | 439 | 179 | 178 | 179 |
營業利益 | -300,386 | 161,681 | 22,196 | -701 | 34,905 | 24,625 | -20,842 | -133,519 | -138,088 | -106,833 |
其他收入及費用 | -83,132 | 10,062 | 11,810 | 14,278 | 6,543 | 15,746 | -12,332 | 118,934 | -374,622 | 5,527 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -383,518 | 171,743 | 34,006 | 13,577 | 41,448 | 40,371 | -33,174 | -14,585 | -512,710 | -101,306 |
所得稅 | 63,990 | 12,694 | 395 | 7,117 | 5,329 | -5,284 | 7,763 | 9,355 | 4,045 | 7,938 |
稅後純益 | -447,508 | 159,049 | 33,611 | 6,460 | 36,119 | 45,655 | -40,937 | -23,940 | -516,755 | -109,244 |
基本每股稅後盈餘(元) | -4.60 | 1.65 | 0.35 | 0.07 | 0.38 | - | -0.46 | -0.27 | -5.86 | -1.24 |
稀釋每股稅後盈餘(元) | -4.60 | 1.56 | 0.34 | 0.07 | 0.37 | 0.76 | -0.45 | -0.25 | -5.86 | -1.24 |
基本平均股數(千股) | 97362.00 | 96283.00 | 95390.00 | 94618.00 | 93991.00 | - | 88889.00 | 88743.00 | 88186.00 | 87841.00 |
稀釋平均股數(千股) | 97362.00 | 108474.00 | 100448.00 | 99144.00 | 99114.00 | - | 88889.00 | 88743.00 | 88186.00 | 87841.00 |
還原基本每股稅後盈餘(元) | -4.60 | 1.65 | 0.35 | 0.07 | 0.38 | - | -0.46 | -0.27 | -5.86 | -1.24 |
還原稀釋每股稅後盈餘(元) | -4.60 | 1.56 | 0.34 | 0.07 | 0.37 | 0.76 | -0.45 | -0.25 | -5.86 | -1.24 |
還原基本平均股數(千股) | 97,362 | 96,283 | 95,390 | 94,618 | 93,991 | - | 88,889 | 88,743 | 88,186 | 87,841 |
還原稀釋平均股數(千股) | 97,362 | 108,474 | 100,448 | 99,144 | 99,114 | - | 88,889 | 88,743 | 88,186 | 87,841 |
EBITDA(千元) | -375,452 | 175,395 | 33,197 | 11,838 | 37,791 | 38,414 | -34,848 | -15,387 | -510,056 | -86,235 |